Back to Results

Lumexa Imaging Holdings Corp (LMRI)

Featured in Small-Cap Stocks

Lumexa Imaging Holdings Corp (NASDAQ: LMRI) is a common stock listing of a healthcare company that owns and operates diagnostic imaging centres in the United States. The company focuses on outpatient imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography for both diagnostic and screening use. Founded in 2018, Lumexa Imaging Holdings is based in Raleigh, North Carolina. As a common equity security on NASDAQ, LMRI represents an ownership interest in the company rather than a fund, debt instrument, or other special listed security.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-LMRI
$14.52
28.7% Upside
Undervalued
$17.29
53.2% Upside
Bargain
Good
—
—
—
0.0%
September 2, 2026
-28.7x
1.8x
1.1x
1.066 B
1.579 B
47.6%
23.0%
1.0
—
-16.4%
Send a message
Valuation • Fair Value

Lumexa Imaging Holdings Corp (NASDAQ-LMRI) Fair Value by Valuation Model

Compare the primary fair value estimate for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$14.52

Estimated upside of 28.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$18.25

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$10.79

Comparable-company valuation reference.

Analyst Price Target

$17.29

Analysts imply upside of 53.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Lumexa Imaging Holdings Corp (NASDAQ-LMRI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.031 B

Current operating scale indicator.

Revenue Forecast

1.068 B

Forward revenue estimate.

EBITDA

85.77 M

Current operating profitability reference.

EBITDA Forecast

237.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Lumexa Imaging Holdings Corp (NASDAQ-LMRI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Lumexa Imaging Holdings Corp (NASDAQ-LMRI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

1.0

Lower score that deserves closer risk review.

FCF / Net Income

-16.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Lumexa Imaging Holdings Corp (NASDAQ-LMRI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Lumexa Imaging Holdings Corp (NASDAQ-LMRI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 2, 2026

Days to Earnings

43

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Lumexa Imaging Holdings Corp (NASDAQ-LMRI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Lumexa Imaging Holdings Corp (NASDAQ-LMRI) Stock Forecast & Technical Outlook

Review Lumexa Imaging Holdings Corp (NASDAQ-LMRI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Lumexa Imaging Holdings Corp (NASDAQ-LMRI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Lumexa Imaging Holdings Corp (NASDAQ-LMRI) has a Strong Buy consensus, with 6 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 6
Hold 0
Sell 0
FAQ • Fast Investor Answers

Lumexa Imaging Holdings Corp (NASDAQ-LMRI) Stock FAQ

Quick answers about Lumexa Imaging Holdings Corp (NASDAQ-LMRI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$14.52
Estimated upside 28.7%
Valuation Rating
Undervalued
Estimated upside of 28.7%
Analyst Target
$17.29
Implied upside 53.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is $14.52. This implies an estimated upside of 28.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 28.7% versus the current market price.

The available analyst price target for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is $17.29. The analyst target implies estimated upside of 53.2%.

The current financial health read for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is September 2, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is -28.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Lumexa Imaging Holdings Corp is 1.066 B.

The current enterprise value listed for Lumexa Imaging Holdings Corp is 1.579 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Lumexa Imaging Holdings Corp is NASDAQ-LMRI, and the stock is listed on NASDAQ.

Lumexa Imaging Holdings Corp (NASDAQ-LMRI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Lumexa Imaging Holdings Corp is 47.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Lumexa Imaging Holdings Corp is 23.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on NASDAQ View more

Guardant Health Inc (GH) Guardant Health Inc (GH)
Brightspring Health Services Inc (BTSG) Brightspring Health Services Inc (BTSG)
Brightspring Health Services Inc Unit (BTSGU) Brightspring Health Services Inc Unit (BTSGU)
The Ensign Group Inc (ENSG) The Ensign Group Inc (ENSG)
Henry Schein Inc (HSIC) Henry Schein Inc (HSIC)
Healthequity Inc (HQY) Healthequity Inc (HQY)
RadNet Inc (RDNT) RadNet Inc (RDNT)
Lifestance Health Group Inc (LFST) Lifestance Health Group Inc (LFST)
Alignment Healthcare LLC (ALHC) Alignment Healthcare LLC (ALHC)
Option Care Health Inc (OPCH) Option Care Health Inc (OPCH)
Privia Health Group Inc (PRVA) Privia Health Group Inc (PRVA)
Acadia Healthcare Company Inc (ACHC) Acadia Healthcare Company Inc (ACHC)
CorVel Corp (CRVL) CorVel Corp (CRVL)
Progyny Inc (PGNY) Progyny Inc (PGNY)
Clover Health Investments Corp (CLOV) Clover Health Investments Corp (CLOV)
Aveanna Healthcare Holdings Inc (AVAH) Aveanna Healthcare Holdings Inc (AVAH)
Surgery Partners Inc (SGRY) Surgery Partners Inc (SGRY)
Addus HomeCare Corporation (ADUS) Addus HomeCare Corporation (ADUS)
Astrana Health Inc (ASTH) Astrana Health Inc (ASTH)
NeoGenomics Inc (NEO) NeoGenomics Inc (NEO)
GeneDx Holdings Corp (WGS) GeneDx Holdings Corp (WGS)
InnovAge Holding Corp (INNV) InnovAge Holding Corp (INNV)
Adapthealth Corp (AHCO) Adapthealth Corp (AHCO)
Pennant Group Inc (PNTG) Pennant Group Inc (PNTG)